Bain Capital allocated half of the capital from its newly established $10.5 billion Asia-focused private equity fund to Japan, representing the firm's largest-ever regional fund, Nikkei Asia reported on Monday.
The firm plans to use the new fund for major Japanese deals, including take-private transactions and divestitures of non-core operations, the news daily said.
Bain's recent deals include the 510 billion yen acquisition of Tanabe Mitsubishi Pharma (now Tanabe Pharma) from Mitsubishi Chemical (TYO:4188) in July 2025, followed by the 810 billion yen purchase of Seven & i's (TYO:3382) supermarket and restaurant subsidiary York Holdings.
By the end of 2025, Bain's global AUM reached 225 billion, with Japan the second-largest market after the U.S.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)